“…In agreement with our previous study that showed that removal of the hydroxyl group from position 8 of the 5nitroquinoline ring resulted in significantly lower catB inhibition (compound 31, Table S3, Supporting Information), 31 the 8-alkyloxy substituted nitroxoline derivatives assayed here also led to diminished activity (compounds 27− 30, Table S2, Supporting Information). Similarly, 8-amino-5nitroquinoline (32), 6-amino-5-nitroquinoline (33), 8-acetamido-5-nitroquinoline (36), and 5,7-dinitro-8-aminoquinoline (37) showed lower catB endopeptidase inhibition when compared with nitroxoline (for compounds 32, 33, 36, and 37, see Table S3, Supporting Information). On the basis of the docking experiments (not shown), we postulate that larger substituents are needed at position 8 of the 5-nitroquinoline, as they can then extend into the S1 and/or S2 subsite of the active site.…”